Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1945 1
1946 2
1947 4
1948 6
1949 6
1950 25
1951 10
1952 21
1953 8
1954 10
1955 5
1956 11
1957 6
1958 8
1959 7
1960 13
1961 15
1962 13
1963 19
1964 22
1965 26
1966 16
1967 17
1968 20
1969 23
1970 17
1971 27
1972 37
1973 42
1974 45
1975 41
1976 44
1977 44
1978 44
1979 34
1980 38
1981 33
1982 60
1983 67
1984 69
1985 77
1986 100
1987 105
1988 151
1989 130
1990 148
1991 180
1992 178
1993 186
1994 184
1995 190
1996 222
1997 230
1998 256
1999 255
2000 283
2001 311
2002 362
2003 339
2004 352
2005 441
2006 490
2007 584
2008 628
2009 770
2010 764
2011 876
2012 837
2013 908
2014 968
2015 1009
2016 1069
2017 1181
2018 1184
2019 1243
2020 1364
2021 1496
2022 1432
2023 1350
2024 508

Text availability

Article attribute

Article type

Publication date

Search Results

21,839 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Yereth
Page 1
Obituary.
Romero NB, Urtizberea JA, Quijano-Roy S. Romero NB, et al. Neuromuscul Disord. 2024 Apr 1;38:42-43. doi: 10.1016/j.nmd.2024.03.008. Online ahead of print. Neuromuscul Disord. 2024. PMID: 38564999 No abstract available.
Lorlatinib CROWNed.
Romero D. Romero D. Nat Rev Clin Oncol. 2021 Jan;18(1):6. doi: 10.1038/s41571-020-00458-w. Nat Rev Clin Oncol. 2021. PMID: 33262501 No abstract available.
From ASCO 2022.
Romero D. Romero D. Nat Rev Clin Oncol. 2022 Aug;19(8):494. doi: 10.1038/s41571-022-00656-8. Nat Rev Clin Oncol. 2022. PMID: 35750856 Free PMC article. No abstract available.
From ESMO 2022.
Romero D. Romero D. Nat Rev Clin Oncol. 2022 Nov;19(11):675. doi: 10.1038/s41571-022-00691-5. Nat Rev Clin Oncol. 2022. PMID: 36180788 Free PMC article. No abstract available.
From ASCO 2023.
Romero D. Romero D. Nat Rev Clin Oncol. 2023 Aug;20(8):503. doi: 10.1038/s41571-023-00792-9. Nat Rev Clin Oncol. 2023. PMID: 37316545 No abstract available.
From WCC 2022.
Romero D. Romero D. Nat Rev Clin Oncol. 2023 Jan;20(1):2. doi: 10.1038/s41571-022-00706-1. Nat Rev Clin Oncol. 2023. PMID: 36329169 Free PMC article. No abstract available.
NELSON updated.
Romero D. Romero D. Nat Rev Clin Oncol. 2020 Apr;17(4):197. doi: 10.1038/s41571-020-0342-x. Nat Rev Clin Oncol. 2020. PMID: 32060417 No abstract available.
From ENA 2021.
Romero D. Romero D. Nat Rev Clin Oncol. 2021 Dec;18(12):748. doi: 10.1038/s41571-021-00575-0. Nat Rev Clin Oncol. 2021. PMID: 34663897 No abstract available.
Uncovering adagrasib resistance.
Romero D. Romero D. Nat Rev Clin Oncol. 2021 Sep;18(9):541. doi: 10.1038/s41571-021-00545-6. Nat Rev Clin Oncol. 2021. PMID: 34267362 No abstract available.
21,839 results
You have reached the last available page of results. Please see the User Guide for more information.